PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Clinical Medicine, Faculty of Health Sciences, University of Aarhus, Denmark; Department of Molecular Medicine, University of Pavia, Italy; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Task Force for Emerging Infections. Basel, Switzerland.\', \'Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.\', \'Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR China.\', \'International Tuberculosis Research Center, Changwon-si, Republic of Korea.\', \'National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, London, United Kingdom.\', \'Directorate General for Disease Control and Prevention, Ministry of Health, Oman.\', \'Biocontainment Treatment Unit, Biosafety for Research-Related Infectious Pathogens, University of Texas Medical Branch, Galveston, TX, USA.\', \'National Institute for Communicable Diseases, A Division of the National Health Laboratory Service, Johannesburg, South Africa.\', \'Division of Infectious Disease, Department of Medicine University Medicine Cluster, National University Hospital, Singapore. Electronic address: mdcpat@nus.edu.sg.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(20)30251-410.1016/j.ijid.2020.04.035
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 32360552
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • COVID-19-We urgently need to start developing an exit strategy.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all